India's Bioeconomy Reaches $195 Billion
Analysis based on 13 articles · First reported Mar 19, 2026 · Last updated Mar 20, 2026
The significant growth of India's bioeconomy to over USD 195 billion in 2025, with a target of USD 300 billion by 2030, indicates a positive outlook for the biotechnology sector. This expansion, supported by the India===Department of Biotechnology (BIRAC) and the BioE3 Policy, is expected to attract further investment and foster innovation in healthcare, agriculture, and sustainable manufacturing, directly impacting related publicly traded companies and the overall Indian market.
India's bioeconomy has experienced substantial growth, expanding from approximately USD 10 billion in 2014 to over USD 195 billion in 2025, with an annual growth rate of 17-18 percent. Union Minister Jitendra Singh announced this at the 14th Foundation Day of the India===Department of Biotechnology (BIRAC), highlighting India's emergence as a major global biotechnology hub. The country aims to achieve a USD 300 billion bioeconomy by 2030, supported by a robust ecosystem of scientists, entrepreneurs, and startups. The BioE3 Policy (Biotechnology for Economy, Environment and Employment) and the Research, Development, and Innovation (RDI) Fund are key government initiatives driving this growth, promoting innovation in areas like precision biotherapeutics, climate-resilient agriculture, and bio-based chemicals. The India Bioeconomy Report 2026 and the BIRAC Impact Report were also released, underscoring the sector's contribution of 4.8 percent to the national GDP and the presence of over 11,800 biotech startups.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard